Siding with a host of better informed longs on Immucor at $15.59. Large short position in company recently drove it down from $30 range, where an activist hedge fund has recently taken a 6% stake. Financial flexible company - debt free with healthy… More
Unless the company does something extraordinary I do not see much upside to this stock. Admitedly Immucor is a leader in the area of blood testing, there is a contract in place with the American Red Cross for 19 Galileo units which will add about $5… More